SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-03-001903
Filing Date
2003-05-15
Accepted
2003-05-15 16:32:54
Documents
4
Period of Report
2003-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q w86535e10vq.htm 10-Q 242888
3 LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREE. w86535exv10w37.txt EX-10.37 88396
4 LOAN AND SECURITY AGREEMENT w86535exv10w38.txt EX-10.38 99096
5 TERM NOTE w86535exv10w39.txt EX-10.39 26591
  Complete submission text file 0000950133-03-001903.txt   458749
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23736 | Film No.: 03705232
SIC: 2834 Pharmaceutical Preparations